The DOI matches its Crossref record; 331 of the 331 references it cites were found in a registry or an index.
mTOR in Brain Physiology and Pathologies
Abstract
TOR (target of rapamycin) and its mammalian ortholog mTOR have been discovered in an effort to understand the mechanisms of action of the immunosuppressant drug rapamycin extracted from a bacterium of the Easter Island (Rapa Nui) soil. mTOR is a serine/threonine kinase found in two functionally distinct complexes, mTORC1 and mTORC2, which are differentially regulated by a great number of nutrients such as glucose and amino acids, energy (oxygen and ATP/AMP content), growth factors, hormones, and neurotransmitters. mTOR controls many basic cellular functions such as protein synthesis, energy metabolism, cell size, lipid metabolism, autophagy, mitochondria, and lysosome biogenesis. In addition, mTOR-controlled signaling pathways regulate many integrated physiological functions of the nervous system including neuronal development, synaptic plasticity, memory storage, and cognition. Thus it is not surprising that deregulation of mTOR signaling is associated with many neurological and psychiatric disorders. Preclinical and preliminary clinical studies indicate that inhibition of mTORC1 can be beneficial for some pathological conditions such as epilepsy, cognitive impairment, and brain tumors, whereas stimulation of mTORC1 (direct or indirect) can be beneficial for other pathologies such as depression or axonal growth and regeneration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–331 of 331
Kim, C. S., Chang, P. Y., & Johnston, D. (2012) · Neuron · doi:10.1016/j.neuron.2012.05.027 · Cited by 158
Ezh2 Regulates Adult Hippocampal Neurogenesis and Memory
Zhang, J., Ji, F., Liu, Y., Lei, X., Li, H., Ji, G., Yuan, Z., & Jiao, J. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4129-13.2014 · Cited by 158
Floto, R. A., Sarkar, S., Perlstein, E. O., Kampmann, B., Schreiber, S. L., & Rubinsztein, D. C. (2007) · Autophagy · doi:10.4161/auto.4898 · Cited by 158
The Late Endosome is Essential for mTORC1 Signaling
Flinn, R. J., Yan, Y., Goswami, S., Parker, P. J., & Backer, J. M. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-09-0756 · Cited by 158
Reinstating Aberrant mTORC1 Activity in Huntington’s Disease Mice Improves Disease Phenotypes
Lee, J. H., Tecedor, L., Chen, Y. H., Mas, A., Sowada, M. J., Thompson, L. M., & Davidson, B. L. (2014) · Neuron · doi:10.1016/j.neuron.2014.12.019 · Cited by 156
Neuropathological role of PI3K/Akt/mTOR axis in Down syndrome brain
Perluigi, M., Pupo, G., Tramutola, A., Cini, C., Coccia, R., Barone, E., Head, E., Butterfield, D. A., & Di Domenico, F. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.007 · Cited by 155
Arrest of Myelination and Reduced Axon Growth When Schwann Cells Lack mTOR
Sherman, D. L., Krols, M., Wu, L.-M. N., Grove, M., Nave, K., Gangloff, Y., & Brophy, P. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.4814-11.2012 · Cited by 154
Niere, F., Wilkerson, J. R., & Huber, K. M. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.4650-11.2012 · Cited by 153
Akt and mTOR mediate programmed necrosis in neurons
Liu, Q., Qiu, J., Liang, M., Golinski, J., van Leyen, K., Jung, J. E., You, Z., Lo, E. H., Degterev, A., & Whalen, M. J. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.69 · Cited by 150
Cao, R., Robinson, B., Xu, H., Gkogkas, C. G., Khoutorsky, A., Alain, T., Yanagiya, A., Nevarko, T., Liu, A. C., Amir, S., et al. (2013) · Neuron · doi:10.1016/j.neuron.2013.06.026 · Cited by 149
Mazei‐Robison, M. S., Koo, J. W., Friedman, A. K., Lansink, C. S., Robison, A. J., Vinish, M., Krishnan, V., Kim, S., Siuta, M., Galli, A., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.10.012 · Cited by 148
Removal of S6K1 and S6K2 leads to divergent alterations in learning, memory, and synaptic plasticityPreprint
Antion, M. D., Merhav, M., Hoeffer, C. A., Reis, G. F., Kozma, S. C., Thomas, G., Schuman, E. M., Rosenblum, K., & Klann, E. (2008) · Learning & Memory · doi:10.1101/lm.661908 · Cited by 146
Li, C., Xiao, L., Liu, X., Yang, W., Shen, W., Hu, C., Yang, G., & He, C. (2013) · Glia · doi:10.1002/glia.22469 · Cited by 145
Aryal, P., Kim, K., Park, P., Ham, S., Cho, J. H., & Song, K. (2014) · FEBS Journal · doi:10.1111/febs.12969 · Cited by 145
Dopaminergic pathway reconstruction by Akt/Rheb‐induced axon regeneration
Kim, S. R., Chen, X. M., Oo, T. F., Kareva, T., Yarygina, O., Wang, C., During, M. J., Kholodilov, N. G., & Burke, R. E. (2011) · Annals of Neurology · doi:10.1002/ana.22383 · Cited by 145
Glutamatergic Regulation of the p70S6 Kinase in Primary Mouse Neurons
Lenz, G., & Avruch, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500363200 · Cited by 143
Zheng, M., Wang, Y., Wu, X., Wu, S., Lu, B.-J., Dong, M., Zhang, H., Sun, P., Lin, S., Guan, K., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2168 · Cited by 143
Dash, P. K., Orsi, S. A., & Moore, A. N. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.0671-06.2006 · Cited by 141
Hypothalamic mTOR Signaling Mediates the Orexigenic Action of Ghrelin
Martins, L., Fernández-Mallo, D., Novelle, M. G., Vazquez, M. J., Tena‐Sempere, M., Nogueiras, R., López, M., & Diéguez, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046923 · Cited by 141
An emerging role for TOR signaling in mammalian tissue and stem cell physiology
Russell, R. C., Fang, C., & Guan, K. (2011) · Development · doi:10.1242/dev.058230 · Cited by 136
Cleary, C., Linde, J. A. S., Hiscock, K. M., Hadas, I., Belmaker, R. H., Agam, G., Flaisher-Grinberg, S., & Einat, H. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.03.005 · Cited by 135
Multi-mechanisms are involved in reactive oxygen species regulation of mTORC1 signaling
Li, M., Zhao, L., Liu, J., Liu, A., Jia, C., Ma, D., Jiang, Y., & Bai, X. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.05.015 · Cited by 134
Rheb1 Is Required for mTORC1 and Myelination in Postnatal Brain Development
Zou, J., Zhou, L., Du, X.-X., Ji, Y.-F., Xu, J., Tian, J., Jiang, W., Zou, Y., Yu, S., Gan, L., et al. (2011) · Developmental Cell · doi:10.1016/j.devcel.2010.11.020 · Cited by 134
Puffenberger, E. G., Strauss, K. A., Ramsey, K. M., Craig, D. W., Stephan, D. A., Robinson, D. L., Hendrickson, C., Gottlieb, S., Ramsay, D. A., Siu, V. M., et al. (2007) · Brain · doi:10.1093/brain/awm100 · Cited by 131
Jiang, M., Ash, R. T., Baker, S. A., Suter, B., Ferguson, A., Park, J., Rudy, J., Torsky, S. P., Chao, H.-T., Zoghbi, H. Y., et al. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1745-13.2013 · Cited by 129
Veenstra-VanderWeele, J., & Blakely, R. D. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.185 · Cited by 128
Wang, Y., Greenwood, J. S. F., Calcagnotto, M. E., Kirsch, H. E., Barbaro, N. M., & Baraban, S. C. (2007) · Annals of Neurology · doi:10.1002/ana.21058 · Cited by 127
Takeuchi, K., Gertner, M. J., Zhou, J., Parada, L. F., Bennett, M. V. L., & Zukin, R. S. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222803110 · Cited by 126
A critical review of mTOR inhibitors and epilepsy: from basic science to clinical trials
Wong, M. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.48 · Cited by 125
Brioni, J. D., Esbenshade, T. A., Garrison, T. R., Bitner, S. R., & Cowart, M. (2010) · Cited by 125
Mealer, R. G., Murray, A. J., Shahani, N., Subramaniam, S., & Snyder, S. H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.536912 · Cited by 124
Mammalian Target of Rapamycin (mTor) Mediates Tau Protein Dyshomeostasis
Tang, Z., Bereczki, E., Zhang, H., Wang, S., Li, C., Ji, X., Branca, R. M., Lehtiö, J., Guan, Z., Filipčík, P., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.435123 · Cited by 124
Rapamycin Prevents Seizures After Depletion of STRADA in a Rare Neurodevelopmental Disorder
Parker, W. E., Orlova, K. A., Parker, W. H., Birnbaum, J. F., Krymskaya, V. P., Goncharov, D. A., Baybis, M., Helfferich, J., Okochi, K., Strauss, K. A., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005271 · Cited by 122
Pten ablation in adult dopaminergic neurons is neuroprotective in Parkinson's disease models
Domanskyi, A., Geißler, C., Vinnikov, I. A., Alter, H., Schober, A., Vogt, M. A., Gass, P., Parlato, R., & Schütz, G. (2011) · The FASEB Journal · doi:10.1096/fj.11-181958 · Cited by 122
Salamon, N., Andres, M., Chute, D. J., Nguyen, S. T. T., Chang, J. W., Huynh, M. N., Chandra, P. S., André, V., Cepeda, C., Levine, M. S., et al. (2005) · Brain · doi:10.1093/brain/awh681 · Cited by 120
Auditory Processing in Fragile X Syndrome
Rotschafer, S. E., & Razak, K. A. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00019 · Cited by 118
Novel Translational Control in Arc-dependent Long Term Potentiation Consolidation in Vivo
Panja, D., Dagytė, G., Bidinosti, M., Wibrand, K., Kristiansen, Å.-M., Sonenberg, N., & Bramham, C. R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.056077 · Cited by 118
Influence of mTOR in energy and metabolic homeostasis
Haissaguerre, M., Saucisse, N., & Cota, D. (2014) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2014.07.015 · Cited by 117
STRADα deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice
Orlova, K. A., Parker, W. E., Heuer, G. G., Tsai, V., Yoon, J. T., Baybis, M., Fenning, R. S., Strauss, K. A., & Crino, P. B. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41592 · Cited by 115
Huntingtin promotes mTORC1 signaling in the pathogenesis of Huntington’s disease
Pryor, W. M., Biagioli, M., Shahani, N., Swarnkar, S., Huang, W., Page, D. T., MacDonald, M. E., & Subramaniam, S. (2014) · Science Signaling · doi:10.1126/scisignal.2005633 · Cited by 114
Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA–induced dyskinesia
Subramaniam, S., Napolitano, F., Mealer, R. G., Kim, S., Errico, F., Barrow, R. K., Shahani, N., Tyagi, R., Snyder, S. H., & Usiello, A. (2011) · Nature Neuroscience · doi:10.1038/nn.2994 · Cited by 111
Hemimegalencephaly: Part 2. Neuropathology Suggests a Disorder of Cellular Lineage
Flores‐Sarnat, L., Sarnat, H. B., Dávila-Gutiérrez, G., & Álvarez, A. (2003) · Journal of Child Neurology · doi:10.1177/08830738030180111101 · Cited by 111
Han, J., Wang, B., Xiao, Z., Gao, Y., Zhao, Y., Zhang, J., Chen, B., Wang, X., & Dai, J. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.06.003 · Cited by 110
Kim, B. W., Choi, M. L., Kim, Y.-S., Park, H., Lee, H., Yun, C., Kim, E. J., Choi, J.-S., Kim, S., Rhim, H., et al. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.12.009 · Cited by 109
Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation
Dai, J., Bercury, K. K., & Macklin, W. B. (2014) · Glia · doi:10.1002/glia.22729 · Cited by 108
Kim, S. R., Kareva, T., Yarygina, O., Kholodilov, N., & Burke, R. E. (2012) · Molecular Therapy · doi:10.1038/mt.2011.213 · Cited by 107
Regulation of TOR by small GTPases
Durán, R. V., & Hall, M. N. (2012) · The EMBO Reports · doi:10.1038/embor.2011.257 · Cited by 102 · cited 1×
“In addition to being targets of mTORC2, Rac-GTP and Rac-GDP activate mTORC2 and mTORC1, providing a positive regulatory loop for actin polymerization (69, 249).”
BackgroundZhou, M., Li, W., Huang, S., Song, J., Kim, J. Y., Tian, X., Kang, E., Sano, Y., Liu, C. M., Balaji, J., et al. (2013) · Neuron · doi:10.1016/j.neuron.2012.12.033 · Cited by 102
Mueller, S., Phillips, J. J., Onar‐Thomas, A., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos140 · Cited by 100
Focal malformations of cortical development: New vistas for molecular pathogenesis
Lim, K., & Crino, P. B. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.07.037 · Cited by 99
Gobert, D., Topolnik, L., Azzi, M., Huang, L., Badeaux, F., DesGroseillers, L., Sossin, W. S., & Lacaille, J. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05470.x · Cited by 98
Berdichevsky, Y., Dryer, A. M., Saponjian, Y., Mahoney, M. M., Pimentel, C., Lucini, C. A., Usenovic, M., & Staley, K. J. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3870-12.2013 · Cited by 98
Rapamycin, Autophagy, and Alzheimer's Disease.
Cai, Z., & Yan, L. (2013) · PubMed · Cited by 98
Siuta, M., Robertson, S. D., Kocalis, H. E., Saunders, C., Gresch, P. J., Khatri, V., Shiota, C., Kennedy, J. P., Lindsley, C. W., Daws, L. C., et al. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000393 · Cited by 98
Meske, V., Albert, F., & Ohm, T. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704292200 · Cited by 95
Dopaminergic Modulation of Auditory Cortex-Dependent Memory Consolidation through mTOR
Schicknick, H., Schott, B. H., Budinger, E., Smalla, K., Riedel, A., Seidenbecher, C. I., Scheich, H., Gundelfinger, E. D., & Tischmeyer, W. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhn026 · Cited by 94
Nascimento, E. B. M., Snel, M., Guigas, B., van der Zon, G. C. M., Kriek, J., Maassen, J. A., Jazet, I. M., Diamant, M., & Ouwens, D. M. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.02.002 · Cited by 93
Roscic, A., Baldo, B., Crochemore, C., Marcellin, D., & Paganetti, P. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07435.x · Cited by 92
mTOR Pathway Overactivation in BRAF Mutated Papillary Thyroid Carcinoma
Faustino, A., Couto, J. P., Pópulo, H., Rocha, A. S., Pardal, F., Cameselle‐Teijeiro, J., Lopes, J. M., Sobrinho-Simões, M. A., & Soares, P. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2748 · Cited by 90
Wang, X., Luo, Y.-X., He, Y.-Y., Li, F.-Q., Shi, H.-S., Xue, L.-F., Xue, Y.-X., & Lu, L. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1264-10.2010 · Cited by 88
Pierce, A. P., Podlutskaya, N., Halloran, J. J., Hussong, S. A., Lin, P., Burbank, R. R., Hart, M. J., & Galván, V. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12080 · Cited by 88
TOR kinase complexes and cell migration
Liu, L., & Parent, C. A. (2011) · Journal of Cell Biology · doi:10.1083/jcb.201102090 · Cited by 87
Pentylenetetrazole‐induced seizures cause acute, but not chronic, mTOR pathway activation in rat
Zhang, B., & Wong, M. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2011.03384.x · Cited by 87
Lost in the jungle: new hurdles for optic nerve axon regeneration
Pernet, V., & Schwab, M. E. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.05.002 · Cited by 87
Chen, B., Wang, L., Huang, K., Wang, C., Chiang, C., & Liu, S. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.05.013 · Cited by 87
Early Progenitor Cell Marker Expression Distinguishes Type II From Type I Focal Cortical Dysplasias
Orlova, K. A., Tsai, V., Baybis, M., Heuer, G. G., Sisodiya, S. M., Thom, M., Strauss, K. A., Aronica, E., Storm, P. B., & Crino, P. B. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181eac1f5 · Cited by 84
Differential Cellular Gene Expression in Ganglioglioma
Samadani, U., Judkins, A. R., Akpalu, A. K., Aronica, E., & Crino, P. B. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.00925.x · Cited by 82
Troca-Marín, J. A., Alves-Sampaio, A., & Montesinos, M. L. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.0011-11.2011 · Cited by 81
A role for the mTOR pathway in surface expression of AMPA receptors
Wang, Y., Barbaro, M. F., & Baraban, S. C. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.03.011 · Cited by 81
Minireview: Nutrient Sensing by G Protein-Coupled Receptors
Wauson, E., Lorente-Rodríguez, A., & Cobb, M. H. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1100 · Cited by 81
Orr, M. E., Salinas, A., Buffenstein, R., & Oddo, S. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.006 · Cited by 78
Rapamycin inhibits the growth of glioblastoma
Arcella, A., Biagioni, F., Oliva, M. A., Bucci, D., Frati, A., Esposito, V., Cantore, G., Giangaspero, F., & Fornai, F. (2012) · Brain Research · doi:10.1016/j.brainres.2012.11.044 · Cited by 77
Long-Term Continuous Corticosterone Treatment Decreases VEGF Receptor-2 Expression in Frontal Cortex
Howell, K. R., Kutiyanawalla, A., & Pillai, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020198 · Cited by 76
Rictor/mTORC2 facilitates central regulation of energy and glucose homeostasis
Kocalis, H. E., Hagan, S. L., George, L., Turney, M. K., Siuta, M., Laryea, G. N., Morris, L. C., Muglia, L. J., Printz, R. L., Stanwood, G. D., et al. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.01.014 · Cited by 76
In vivo evidence for mTORC2-mediated actin cytoskeleton rearrangement in neurons
Angliker, N., & Rüegg, M. A. (2013) · BioArchitecture · doi:10.4161/bioa.26497 · Cited by 74
Park, J., Zhang, J., Qiu, J., Zhu, X., Degterev, A., Lo, E. H., & Whalen, M. J. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.131 · Cited by 74
Yadav, R. B., Burgos, P., Parker, A. W., Iadevaia, V., Proud, C. G., Allen, R. A., O’Connell, J. P., Jeshtadi, A., Stubbs, C. D., & Botchway, S. W. (2013) · BMC Cell Biology · doi:10.1186/1471-2121-14-3 · Cited by 72
Wijetunge, L. S., Angibaud, J., Frick, A., Kind, P. C., & Nägerl, U. V. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.5302-13.2014 · Cited by 72
Blancquaert, S., Wang, L., Paternot, S., Coulonval, K., Dumont, J. E., Harris, T. E., & Roger, P. P. (2010) · Molecular Endocrinology · doi:10.1210/me.2010-0087 · Cited by 71
Targeting mTOR as a novel therapeutic strategy for traumatic CNS injuries
Don, A. S. A., Tsang, C. K., Kazdoba, T. M., D’Arcangelo, G., Young, W., & Zheng, X. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.04.010 · Cited by 70
mTOR Hyperactivation in Down Syndrome Hippocampus Appears Early During Development
Iyer, A. M., van Scheppingen, J., Milenkovic, I., Anink, J. J., Adle-Biassette, H., Kovacs, G. G., & Aronica, E. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000083 · Cited by 69
Lang, U. E., Heger, J., Wilbring, M., Domula, M., Matschke, K., & Tugtekin, S. (2009) · Transplantation Proceedings · doi:10.1016/j.transproceed.2009.08.050 · Cited by 69
Ehninger, D. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.05.015 · Cited by 68
Yu, J.-J., Zhang, Y., Wang, Y., Wen, Z.-Y., Liu, X., Qin, J., & Yang, J.-L. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2823-9 · Cited by 68
RTP801/REDD1 Regulates the Timing of Cortical Neurogenesis and Neuron Migration
Malagelada, C., López-Toledano, M. A., Willett, R. T., Jin, Z. H., Shelanski, M. L., & Greene, L. A. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4011-10.2011 · Cited by 67
Collo, G., Bono, F., Cavalleri, L., Plebani, L., Mitola, S. M. F., Pich, E. M., Millan, M. J., Zoli, M., Maskos, U., Spano, P., et al. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.084863 · Cited by 67
Kim, H. W., Ha, S. H., Lee, M. N., Huston, E., Kim, D., Jang, S. K., Suh, P., Houslay, M. D., & Ryu, S. H. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00217-10 · Cited by 67
BRAFV600E Negatively Regulates the AKT Pathway in Melanoma Cell Lines
Chen, B., Tardell, C., Higgins, B., Packman, K. E., Boylan, J. F., & Niu, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042598 · Cited by 66
Pivotal Role of mTORC2 and Involvement of Ribosomal Protein S6 in Cardioprotective Signaling
Yano, T., Ferlito, M., Aponte, A. M., Kuno, A., Miura, T., Murphy, E., & Steenbergen, C. (2014) · Circulation Research · doi:10.1161/circresaha.114.303562 · Cited by 66
Loss of the tuberous sclerosis complex protein tuberin causes Purkinje cell degeneration
Reith, R. M., Way, S., McKenna, J., Haines, K., & Gambello, M. J. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.02.014 · Cited by 65
Fishwick, K. J., Li, R. A., Halley, P. A., Deng, P., & Storey, K. G. (2009) · Developmental Biology · doi:10.1016/j.ydbio.2009.12.001 · Cited by 65
Shih, M.-H., Kao, S.-C., Wang, W., Yaster, M., & Tao, Y. (2012) · Journal of Pain · doi:10.1016/j.jpain.2011.12.006 · Cited by 63
Paintlia, A. S., Paintlia, M. K., Mohan, S., Singh, A. K., & Singh, I. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.04.030 · Cited by 62
Rapamycin attenuates the expression of cocaine‐induced place preference and behavioral sensitization
Bailey, J., Ma, D., & Szumlinski, K. K. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2010.00311.x · Cited by 61
Chapter 13 Autophagy Pathways in Glioblastoma
Jiang, H., White, E. J., Conrad, C. A., Gomez‐Manzano, C., & Fueyo-Margareto, J. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)04013-5 · Cited by 60
Co-expression of cyclin D1 and phosphorylated ribosomal S6 proteins in hemimegalencephaly
Aronica, E., Boer, K., Baybis, M., Yu, J., & Crino, P. B. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0225-6 · Cited by 59
Gant, J. C., Chen, K.-C., Norris, C. M., Kadish, I., Thibault, O., Blalock, E. M., Porter, N. M., & Landfield, P. W. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4805-10.2011 · Cited by 58
mTORC1-dependent protein synthesis underlying rapid antidepressant effect requires GABABR signaling
Workman, E. R., Niere, F., & Raab‐Graham, K. F. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.037 · Cited by 57
Parkin loss of function contributes to RTP801 elevation and neurodegeneration in Parkinson’s disease
Romaní-Aumedes, J., Canal, M., Martín‐Flores, N., Sun, X., Pérez-Fernández, V., Wewering, S., Fernández‐Santiago, R., Ezquerra, M., Pont‐Sunyer, C., Lafuente, A., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.333 · Cited by 56
The Mammalian Target of Rapamycin Pathway as a Potential Target for Cancer Chemoprevention
Kopelovich, L., Fay, J. R., Sigman, C. C., & Crowell, J. A. (2007) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0045 · Cited by 55
Rhes Deletion Is Neuroprotective in the 3-Nitropropionic Acid Model of Huntington's Disease
Mealer, R. G., Subramaniam, S., & Snyder, S. H. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3730-12.2013 · Cited by 55
Lafourcade, C., Lin, T. V., Feliciano, D. M., Zhang, L., Hsieh, L. S., & Bordey, A. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.1840-12.2013 · Cited by 53
mTOR signaling in neural stem cells: from basic biology to disease
Magri, L., & Galli, R. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1196-x · Cited by 52
Rheb and mammalian target of rapamycin in mitochondrial homoeostasis
Groenewoud, M. J., & Zwartkruis, F. J. T. (2013) · Open Biology · doi:10.1098/rsob.130185 · Cited by 51
Ran, I., Gkogkas, C. G., Vasuta, C., Tartas, M., Khoutorsky, A., Laplante, I., Parsyan, A. E., Nevarko, T., Sonenberg, N., & Lacaille, J. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3264-12.2013 · Cited by 50
Ma, Y., Wu, D., & LIU, J.-K. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.1186 · Cited by 49
Zhu, X., Park, J., Golinski, J., Qiu, J., Khuman, J., Lee, C. C. H., Lo, E. H., Degterev, A., & Whalen, M. J. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.113 · Cited by 46
Baiamonte, B. A., Lee, F. A., Brewer, S. T., Spano, D., & LaHoste, G. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053606 · Cited by 45
Lyu, D., Yu, W., Tang, N., Wang, R., Zhao, Z., Xie, F., He, Y., Du, H., & Chen, J. (2013) · Molecular Pain · doi:10.1186/1744-8069-9-64 · Cited by 45
5-HT6 Receptor Recruitment of mTOR Modulates Seizure Activity in Epilepsy
Wang, L., Lv, Y., Deng, W., Peng, X., Xiao, Z., Xi, Z., Chen, G., & Wang, X. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8806-6 · Cited by 44
GADD34 mediates cytoprotective autophagy in mutant huntingtin expressing cells via the mTOR pathway
Hyrskyluoto, A., Reijonen, S., Kivinen, J., Lindholm, D., & Korhonen, L. (2011) · Experimental Cell Research · doi:10.1016/j.yexcr.2011.08.020 · Cited by 43
Yasuda, S., Sugiura, H., Katsurabayashi, S., Shimada, T., Tanaka, H., Takasaki, K., Iwasaki, K., Kobayashi, T., Hino, O., & Yamagata, K. (2014) · Scientific Reports · doi:10.1038/srep05155 · Cited by 43
Gangarossa, G., Ceolin, L., Paucard, A., Lerner‐Natoli, M., Perroy, J., Fagni, L., & Valjent, E. (2014) · Hippocampus · doi:10.1002/hipo.22327 · Cited by 41
Salles, M., Hervé, D., Rivet, J., Longueville, S., Millan, M. J., Girault, J., & la Cour, C. M. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12206 · Cited by 41
Ismail, H. M. (2012) · Journal of Oncology · doi:10.1155/2012/416927 · Cited by 39
mTOR Signaling and Entrainment of the Mammalian Circadian Clock.
Cao, R., & Obrietan, K. H. (2010) · PubMed · doi:10.4255/mcpharmacol.10.17 · Cited by 37
Gafford, G. M., Parsons, R. G., & Helmstetter, F. J. (2013) · Hippocampus · doi:10.1002/hipo.22140 · Cited by 37
Mori, K., Mori, T., Toda, Y., Fujii, E., Miyazaki, M., Harada, M., & Kagami, S. (2011) · Brain and Development · doi:10.1016/j.braindev.2011.09.001 · Cited by 32
James, M. H., Quinn, R. K., Ong, L. K., Levi, E. M., Charnley, J. L., Smith, D. W., Dickson, P. W., & Dayas, C. V. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.16 · Cited by 32
Lee, K. M., Yang, S., Choi, J., & Park, C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.523423 · Cited by 29
mTOR signaling contributes to motor skill learning in mice
Bergeron, Y., Chagniel, L., Bureau, G. ̈., Massicotte, G., & Cyr, M. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00026 · Cited by 29
Axonal protein synthesis and the regulation of primary afferent function
Obara, I., & Hunt, S. P. (2013) · Developmental Neurobiology · doi:10.1002/dneu.22133 · Cited by 27
Russo, E., Follesa, P., Citraro, R., et al. (2014) · Neurological Sciences · doi:10.1007/s10072-014-1842-1 · Cited by 27
Bicyclic triterpenoid Iripallidal induces apoptosis and inhibits Akt/mTOR pathway in glioma cells
Koul, N., Sharma, V., Dixit, D., Ghosh, S., & Sen, E. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-328 · Cited by 27
PI3K/mTOR signaling pathways in medulloblastoma.
MOHAN, A. L., Friedman, M. D., Ormond, D. R., Tobias, M. E., Murali, R., & Jhanwar‐Uniyal, M. (2012) · PubMed · Cited by 24
TSC on the peroxisome controls mTORC1
Benjamin, D., & Hall, M. N. (2013) · Nature Cell Biology · doi:10.1038/ncb2849 · Cited by 21
Suer, S., Zhang, B., Hussain, A., & Burger, A. M. (2011) · Cancer Research · doi:10.1158/1538-7445.am2011-4366 · Cited by 18
mTOR/PRAS40 interaction: Hypertrophy or proliferation
Völkers, M., & Sussman, M. A. (2013) · Cell Cycle · doi:10.4161/cc.26822 · Cited by 17
Association of the Small GTPase Rheb with the NMDA Receptor Subunit NR3A
Sucher, N. J., Yu, E. C.-W., Chan, S. F., Miri, M. L., Lee, B. J., Xiao, B., Worley, P. F., & Jensen, F. E. (2010) · Neurosignals · doi:10.1159/000322206 · Cited by 17
Wang, S., Wu, J., Nie, S., Bereczki, E., & Pei, J.-J. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130641 · Cited by 15
Caveat mTOR: aberrant signaling disrupts corticogenesis
Osborne, L. R. (2010) · Journal of Clinical Investigation · doi:10.1172/jci43030 · Cited by 7
Cited by
Intermittent metabolic switching, neuroplasticity and brain health
Mattson, M. P., Moehl, K., Ghena, N., Schmaedick, M., & Cheng, A. (2018) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.156 · Cited by 624
A cannabinoid link between mitochondria and memory
Hebert-Chatelain, E., Desprez, T., Serrat, R., Bellocchio, L., Soria-Gomez, E., Busquets-Garcia, A., Pagano Zottola, A. C., Delamarre, A., Cannich, A., Vincent, P., et al. (2016) · Nature · doi:10.1038/nature20127 · Cited by 434
The mTOR signalling cascade: paving new roads to cure neurological disease
Crino, P. B. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.81 · Cited by 368
Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration
Querfurth, H., & Lee, H.-K. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00428-5 · Cited by 288
Bioenergetics and redox adaptations of astrocytes to neuronal activity
Bolaños, J. P. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13486 · Cited by 262
Metadata
- Authors
- Bockaert, J., & Marin, P.
- Venue
- Physiological Reviews
- Publisher
- American Physiological Society
- Published
- 2015-10
- Volume
- 95
- Issue
- 4
- Pages
- 1157-1187
- ISSN
- 0031-9333 (ISSN-L)
- 1522-1210
- OpenAlex
- W2333152282
- Cited by
- 356
- References
- 331
- FWCI
- 2.09
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.